Expertise in
27
conditions

Dr. Mark J. Stavas

Radiation Oncology
Cancer Partners Of Nebraska PC
4101 Tiger Lily Rd Ste 100, 
Lincoln, NE 
Accepting New Patients
Expertise in
27
conditions
Cancer Partners Of Nebraska PC
4101 Tiger Lily Rd Ste 100, 
Lincoln, NE 

Overview

Mark Stavas is a Radiation Oncologist practicing medicine in Lincoln, Nebraska.

Dr. Stavas is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 3 clinical trials. Dr. Stavas is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in TN

Hospital Affiliations

York General Health Care Services
Chi Health St. Elizabeth
Bryan Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Cancer Partners of Nebraska PC
4101 Tiger Lily Rd Ste 100, Lincoln, NE 68516
Other Locations
Southeast Nebraska Hematology and Oncology Consultants PC
201 S 68th Street Pl Ste 200, Lincoln, NE 68510

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying Treatment for NOde Positive Prostate Cancer by VArying the Hormonal ThErapy
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Hormone therapy, Prednisone
Study Phase: Phase 3
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

18 Total Publications

An Integrative Medicine Educational Program for Radiation Oncology Patients: Patient-Reported Outcomes.
An Integrative Medicine Educational Program for Radiation Oncology Patients: Patient-Reported Outcomes.
Journal: Advances in radiation oncology
Published: June 06, 2023
Similar Doctors
Expertise in
33
conditions
Dr. Joseph K. Kam Chiu
Radiation Oncology
Expertise in
33
conditions
Dr. Joseph K. Kam Chiu
Radiation Oncology
Referral may be required

CHI Health Radiation Oncology (ST. Elizabeth)

555 S 70th St, 
Lincoln, NE 
 (5.1 miles away)
402-219-7930
Languages Spoken:
English, Afrikaans, Cantonese, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Joseph Kam Chiu is a Radiation Oncologist practicing medicine in Lincoln, Nebraska. Dr. Kam Chiu is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Astrocytoma, Oligodendroglioma, Breast Cancer, and Gamma Knife Radiosurgery. Dr. Kam Chiu is currently accepting new patients.

Expertise in
20
conditions
Dr. Weining K. Zhen
Radiation Oncology
Expertise in
20
conditions
Dr. Weining K. Zhen
Radiation Oncology
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
 (49.9 miles away)
402-559-5600
Languages Spoken:
English, American Sign Language, Japanese, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Weining Zhen is a Radiation Oncologist practicing medicine in Omaha, Nebraska. Dr. Zhen is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Laryngeal Cancer, and Gastrostomy. Dr. Zhen is currently accepting new patients.

Expertise in
11
conditions
Dr. Kevin Yiee
Radiation Oncology
Expertise in
11
conditions
Dr. Kevin Yiee
Radiation Oncology
Referral may be required

CHI Health Clinic Heart Institute - Lincoln (St. Elizabeth)

555 S 70th St, 
Lincoln, NE 
 (5.1 miles away)
402-489-6555
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Yiee is a Radiation Oncologist practicing medicine in Lincoln, Nebraska. Dr. Yiee is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Familial Prostate Cancer. Dr. Yiee is currently accepting new patients.

Frequently Asked Questions about Dr. Mark J. Stavas

How do I make an appointment with Dr. Mark J. Stavas?

You can book an appointment with Dr. Mark J. Stavas by calling their office at 402-420-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark J. Stavas a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark J. Stavas is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark J. Stavas specialize in?

While Dr. Mark J. Stavas is a Radiation Oncology, they have specific expertise in Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mark J. Stavas participate in research or clinical trials?

Yes. Dr. Mark J. Stavas has published 18 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Mark J. Stavas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark J. Stavas accept my insurance?

Dr. Mark J. Stavas accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 402-420-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stavas's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile